Union Chimique Beige

Other processes, including the SocifitH Beige de 1 Azote and Union Chimique Beige (22) are designed to achieve even higher heat recovery which is inherently possible through use of pressure neutralization. 

Morren, H. U.S. Patent 2,899,436 August 11, 1959 assigned to Union Chimique Beige Soclete Anonyme, Belgium... 

Created in 1928 by the merger of thirteen chemical intermediate factories, Union Chimique Beige (UCB) has continuously used mergers, acquisitions, and divestments to strengthen its position in those markets that were consistent with its strategy of innovation and globalization , first in chemicals and films and later also in pharmaceuticals. 

Union Chimique Beige was founded in 1928 by, among others, Baron Emmanuel Janssen, who was married to a granddaughter of Ernest Solvay, the founder of Sol-vay, the other Belgian hybrid chemical/pharmaceutical company. At that time, Union Chimique Beige was producing several heavy chemical intermediates such as ammonia, sulfuric acid, sodium sulfide, and coal derivatives. 

During the Second World War, Union Chimique Beige started producing basic pharmaceuticals such as calcium, phosphor, vitamins, insulin, and sulfamides. However, it was only in the late fifties that it launched, with limited market impact, its first real pharmaceutical products - Postafene (an anti-histamine), Atarax (a tranquilizer) and Tuclase (a cough and cold drug) - and concluded a first license agreement with Pfizer for the distribution of Atarax in the U.S. 

In 1961, the current UCB was formed through the merger of Union Chimique Beige (briefly described above), Fabelta (an artificial textile fiber producer) and Sidac (a cellulose film manufacturer). 

L14. Loos, R., Aper u des methodes employees dans l electrophorese sur papier. lste Colloq. Sint Jans Hospitaal, Brugge pp. 21-27. Union Chimique Beige S.A., Bruxelles. (1953). 

A. Goneberg, A. Verheyden, Belgian Patent 510 419 (to Union chimique beige Soc.), 1952 ... 

---